The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases

Hepato-Gastroenterology

Volumn 59, Issue 115, 2012, Pages 826-830

  Tamano, Masaya ^a   Kojima, Kazuo ^a   Akima, Takashi ^a   Murohisa, Toshimitsu ^a   Hashimoto, Takashi ^a   Uetake, Chizu ^a   Sugaya, Takeshi ^a   Nakano, Masakazu ^a   Hiraishi, Hideyuki ^a   Yoneda, Masashi ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatic fibrosis; Non alcoholic steato hepatitis; Transient elastography

Indexed keywords

HYALURONIC ACID;

ARTICLE; BLOOD LEVEL; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEVICES; DIAGNOSTIC VALUE; ELASTOGRAPHY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MEASUREMENT; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SERUM; TRANSIENT ELASTOGRAPHY; VIRUS HEPATITIS;

BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; ELASTICITY; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; JAPAN; LIVER; LIVER CIRRHOSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 84860511562     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11255     Document Type: Article

References (23)

1. Benvegnu L, Gios M, Boccato S, Alberti A: Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004; 53:744-9. (Pubitemid 38561455)
2. Regev A, Berho M, Jeffers LJ, et al.: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97:2614-8.
3. Bedossa P, Dargere D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatol 2003; 38:1449-57. (Pubitemid 37466971)
4. Piccinino F, Sagnelli E, Pasquale G, Giusti G: Complications following percutaneous liver biopsy. A multicentre retrospective study on 68.276 biopsies. J Hepatology 1986; 2:165-73. (Pubitemid 16125908)
5. Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V: FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology 2006; 43:373-4; author reply 5-6.
6. Foucher J, Chanteloup E, Vergniol J, et al.: Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55:403-8. (Pubitemid 43268281)
7. Ganne-Carrie N, Ziol M, de Ledinghen V, et al.: Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44:1511-7. (Pubitemid 44953656)
8. Friedrich-Rust M, Ong MF, Herrmann E, et al.: Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. AJR Am J Roentgenol 2007; 188:758-64.
9. Ogawa E, Furusyo N, Toyoda K, et al.: Transient elastography for patients with chronic hepatitis B and C virus infection: Non-invasive, quantitative assessment of liver fibrosis. Hepatol Res 2007; 37:1002-10. (Pubitemid 350028326)
10. Yoneda M, Fujita K, Inamori M, et al.: Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56:1330-1. (Pubitemid 47300449)
11. Yoneda M, Mawatari H, Fujita K, et al.: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with non-alcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008; 40:371-8.
12. Sandrin L, Fourquet B, Hasquenoph JM, et al.: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29:1705-13. (Pubitemid 38091720)
13. Kim KM, Choi WB, Park SH, et al.: Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroenterol 2007; 42:382-8. (Pubitemid 47097255)
14. Del Poggio P, Colombo S: Is transient elastography a useful tool for screening liver disease? World J Gastroenterol 2009; 15:1409-14.
15. Kim SU, Choi GH, Han WK, et al.: What are 'true normal' liver stiffness values using FibroScan?: A prospective study in healthy living liver and kidney donors in South Korea. Liver Int 2009; 30(2):268-74.
16. Seo YS, Um SH, Suh SJ, et al.: Changes in liver stiffness during the course of acute hepatitis A. Korean J Hepatol 2008; 14:465-73.
17. Wong GL, Wong VW, Choi PC, et al.: Increased liver stiffness measurement by transient elastography in severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol 2009; 24:1002-7.
18. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-20. (Pubitemid 24166476)
19. Hubscher SG: Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006; 49:450-65.
20. Guechot J, Loria A, Serfaty L, Giral P, Giboudeau J, Poupon R: Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy. J Hepatol 1995; 22:22-6.
21. Korner T, Kropf J, Gressner AM: Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol 1996; 25:684-8. (Pubitemid 26373886)
22. Pares A, Deulofeu R, Gimenez A, et al.: Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996; 24:1399-403. (Pubitemid 26399038)
23. Laurent TC, Laurent UB, Fraser JR: Serum hyaluronan as a disease marker. Ann Med 1996; 28:241-53. (Pubitemid 26191062)